# A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds

> **NCT07594158** · PHASE3 · RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Partial Epilepsy

## Interventions

- **DRUG:** Cenobamate (tablet) for 12 to < 18 year olds
- **DRUG:** Cenobamate (syrup) for 2 to < 18 year olds

## Key facts

- **NCT ID:** NCT07594158
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2028-03-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07594158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07594158, "A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07594158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*